CD02_OpenLabel Investigational Site — Orlando, Florida

CD02_OpenLabel Investigational Site is a clinical research site located in Orlando, Florida, United States 32803.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

CD02_OpenLabel Investigational Site has participated in 1 clinical trials.

Therapeutic areas: HIV-1-infection.

Sponsors: CytoDyn, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CD02_OpenLabel Investigational Site?

CD02_OpenLabel Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CD02_OpenLabel Investigational Site conducted?

CD02_OpenLabel Investigational Site has 1 clinical trials on record. Their work covers HIV-1-infection.

Is CD02_OpenLabel Investigational Site accredited by Crixeo Health?

CD02_OpenLabel Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CD02_OpenLabel Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.